1. Home
  2. CSIQ vs TYRA Comparison

CSIQ vs TYRA Comparison

Compare CSIQ & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$22.86

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$22.54

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSIQ
TYRA
Founded
2001
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.2B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
CSIQ
TYRA
Price
$22.86
$22.54
Analyst Decision
Sell
Strong Buy
Analyst Count
9
5
Target Price
$17.63
$31.20
AVG Volume (30 Days)
5.5M
570.8K
Earning Date
11-13-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,899,139,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$29.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.57
$6.42
52 Week High
$34.59
$24.05

Technical Indicators

Market Signals
Indicator
CSIQ
TYRA
Relative Strength Index (RSI) 46.94 69.31
Support Level $22.21 $21.66
Resistance Level $25.45 $24.05
Average True Range (ATR) 2.17 1.31
MACD -0.58 -0.05
Stochastic Oscillator 8.55 67.04

Price Performance

Historical Comparison
CSIQ
TYRA

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects.. It operates through two business segments CSI Solar and Recurrent Energy segment. The CSI Solar segment focused on solar modules and battery energy storage manufacturing and products. Its Recurrent segment focused on utility-scale solar power and battery energy storage project development and operation. Key revenue is generated from CSI Solar segment.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: